Posted on 11/16/20
Advent Technologies Collaboration With Los Alamos National Laboratory
NEW YORK--(BUSINESS WIRE)--AMCI Acquisition Corp. (NASDAQ: AMCI) today announced that Advent Technologies – with which AMCI has entered into a definitive agreement and plan of merger for . . .
Posted on 11/16/20
Pfizer Combine Its Upjohn Business with Mylan
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. . . .
Posted on 11/16/20
Legend Biotech Reports Third Quarter 2020 Financial Results
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other . . .
Posted on 11/16/20
This Is What a Comcast-Walmart TV Partnership Would Really Be About
Cable giant Comcast (NASDAQ:CMCSA) and retailer Walmart (NYSE:WMT) may be teaming up to make television sets, according to recent reports from The Wall Street Journal.Neither company . . .
Posted on 11/16/20
Why You Shouldn't Ignore Johnson & Johnson
The year 2020 has been full of surprises. Growth stocks, which are usually the first to get battered during economic downturns, have performed exceptionally well, while . . .
Posted on 11/16/20
These 3 Stocks Rallied 10% After Pfizer's Vaccine News: Here's Why They're Still Buys
Pfizer's Nov. 9 announcement that it's making progress toward a COVID-19 vaccine caused markets to rally, with beaten down sectors including airlines, industrials, and retailers leading . . .
Posted on 11/16/20
Here's Why Pfizer's Coronavirus Vaccine Would Be Revolutionary
Fool.com's Healthcare and Cannabis Bureau Chief Corinne Cardina interviewed Richard Horton on Motley Fool Live on Oct. 9. Horton runs the British medical journal The Lancet . . .
Posted on 11/16/20
The Biggest Takeaway From Pfizer's Coronavirus Vaccine Results
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) created a firestorm (in a good way) when they announced interim efficacy results for their coronavirus vaccine candidate BNT162b2 last Monday. Motley Fool . . .
Posted on 11/13/20
Prevail Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative . . .
Posted on 11/13/20
Vaccinex Reports Third Quarter 2020 Financial Results and Provides Corporate Update
ROCHESTER, N.Y., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company developing innovative therapies for the treatment of neurodegenerative diseases and . . .
Posted on 11/13/20
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
CRANBURY, N.J., Nov. 13, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic . . .
Posted on 11/13/20
Pfizer CEO Sold Shares on Same Day as the Company's Coronavirus Vaccine News: Should You Be Outraged?
This seems like another story of the greed of corporate executives, at least at first glance. On Monday, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced exciting news. . . .
Posted on 11/13/20
Vesey Street Capital Partners Announces Recapitalization of QualityMetric
Vesey Street Capital Partners, LLC, a New York-based healthcare services private equity firm, announced that funds managed by VSCP have completed a recapitalization of QualityMetric, an . . .
Posted on 11/12/20
TYME Provides Business Update and Announces Second Quarter Fiscal 2021 Financial and Operating Results
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial and operating results for its second quarter ended . . .
Posted on 11/12/20
Akers Biosciences and MyMD Pharmaceuticals Merges
MyMD Pharmaceuticals, Inc. and Akers Biosciences, Inc. (NASDAQ: AKER) today jointly announced that they have entered into a definitive merger agreement.
Posted on 11/12/20
Eyenovia Reports Third Quarter 2020 Financial Results
NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print therapeutics, . . .
Posted on 11/12/20
Osmotica Pharmaceuticals plc Reports Third Quarter 2020 Results and Provides Business Updates
BRIDGEWATER, N. J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced business highlights and financial results . . .
Posted on 11/12/20
Royalty Pharma Reports Third Quarter 2020 Results
NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the third quarter of 2020 and updated full-year . . .
Posted on 11/12/20
J. Knipper and Company to Acquire Eagle Pharmacy
LAKEWOOD, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- J. Knipper and Company, Inc., one of the largest suppliers of end-to-end pharmaceutical healthcare marketing services and solutions . . .
Posted on 11/12/20
PDS Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update
FLORHAM PARK, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines . . .
Posted on 11/12/20
Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results
BERKELEY HEIGHTS, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company developing innovative medicines based on cancer cell . . .
Posted on 11/12/20
Applied Therapeutics Reports Third Quarter 2020 Financial Results
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated . . .
Posted on 11/12/20
BioXcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
NEW HAVEN, Conn., Nov. 12, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience . . .
Posted on 11/12/20
SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
STAMFORD, Conn., Nov. 12, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe . . .
Posted on 11/12/20
HOOKIPA Pharma Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
NEW YORK and VIENNA, Austria, Nov. 12, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK’), a company developing a new class of immunotherapeutics based on . . .
New York
